Endotoxin-induced endothelial fibrosis is dependent on expression of transforming growth factors β1 and β2

dc.contributor.authorEcheverría, César
dc.contributor.authorMontorfano, Ignacio
dc.contributor.authorTapia, Pablo
dc.contributor.authorRiedel, Claudia
dc.contributor.authorCabello-Verrugio, Claudio
dc.contributor.authorSimon, Felipe
dc.date.accessioned2023-07-21T16:59:02Z
dc.date.available2023-07-21T16:59:02Z
dc.date.issued2014
dc.descriptionIndexación: Scopus.es
dc.description.abstractDuring endotoxemia-induced inflammatory disease, bacterial endotoxins circulate in the bloodstream and interact with endo thelial cells (ECs), inducing dysfunction of the ECs. We previously reported that endotoxins induce the conversion of ECs into activated fibroblasts. Through endotoxin-induced endothelial fibrosis, ECs change their morphology and their protein expres sion pattern, thereby suppressing endothelial markers and upregulating fibrotic proteins. The most commonly used fibrotic in ducers are transforming growth factor 1 (TGF- 1) and TGF- 2. However, whether TGF- 1 and TGF- 2 participate in endo toxin-induced endothelial fibrosis remains unknown. We have shown that the endotoxin-induced endothelial fibrosis process is dependent on the TGF- receptor, ALK5, and the activation of Smad3, a protein that is activated by ALK5 activation, thus sug gesting that endotoxin elicits TGF- production to mediate endotoxin-induced endothelial fibrosis. Therefore, we investigated the dependence of endotoxin-induced endothelial fibrosis on the expression of TGF- 1 and TGF- 2. Endotoxin-treated ECs induced the expression and secretion of TGF- 1 and TGF- 2. TGF- 1 and TGF- 2 downregulation inhibited the endotoxin induced changes in the endothelial marker VE-cadherin and in the fibrotic proteins -SMA and fibronectin. Thus, endotoxin in duces the production of TGF- 1 and TGF- 2 as a mechanism to promote endotoxin-induced endothelial fibrosis. To the best of our knowledge, this is the first report showing that endotoxin induces endothelial fibrosis via TGF- secretion, which represents an emerging source of vascular dysfunction. These findings contribute to understanding the molecular mechanism of endotox in-induced endothelial fibrosis, which could be useful in the treatment of inflammatory diseaseses
dc.description.urihttps://journals-asm-org.recursosbiblioteca.unab.cl/doi/10.1128/IAI.02158-14
dc.identifier.citationInfection and Immunity. Volume 82, Issue 9, Pages 3678 - 3686. 2014es
dc.identifier.doi10.1128/IAI.02158-14
dc.identifier.issn0019-9567
dc.identifier.urihttps://repositorio.unab.cl/xmlui/handle/ria/51908
dc.language.isoenes
dc.publisherAmerican Society for Microbiologyes
dc.rights.licenseAtribution 4.0 International (CC BY 4.0)
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/deed.es
dc.subjectEndothelial Fibrosises
dc.subjectEndothelial Cells (ECs)es
dc.subjectTGF- β2es
dc.subjectTGF-β1)es
dc.subjectInflammatory Diseasees
dc.subjectBacterial Endotoxinses
dc.titleEndotoxin-induced endothelial fibrosis is dependent on expression of transforming growth factors β1 and β2es
dc.typeArtículoes
Archivos
Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Echeverria_Endotoxin-induced_endothelial_fibrosis_is_dependent_2014.pdf
Tamaño:
2.45 MB
Formato:
Adobe Portable Document Format
Descripción:
TEXTO COMPLETO EN INGLÉS
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción: